Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: August 28, 2026
Reporting Period: Single event date (August 28, 2026)
Business Context: The filing serves as a Regulation FD disclosure to furnish an investor presentation made available on the company's website regarding its business and operations.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure notice referencing an external presentation (Exhibit 99.1) rather than a financial statement containing quantitative data.
Material Changes
No material changes to financial performance or operations are detailed within the text of this filing. The document solely announces the availability of a presentation to investors.
Guidance, Outlook, and Risks
Management Commentary: The company furnished a presentation to investors on August 28, 2026. The content of this presentation is not included in the filing text but is accessible via the company's investor website.
Legal Status: The information in Item 7.01 and Exhibit 99.1 is furnished and not deemed "filed" under the Exchange Act, nor is it incorporated by reference unless specifically identified as such.
Risks and Contingencies: No specific risks or contingencies are disclosed in this text.
Investor Verification Checklist
- Access the investor presentation (Exhibit 99.1) at www.ibs.inc to review the actual business and operational details.
- Verify the trading status of Common Stock (Symbol: INBS) on The Nasdaq Stock Market LLC.
- Confirm the identity of the authorized signatory, Spiro Sakiris, Chief Financial Officer.
- Note that the presentation content is not legally "filed" with the SEC and may not be incorporated by reference in other filings.